Ultragenyx outlines 2027 profitability plan with R&D under $350M and SG&A under $375M following GTX-102 discontinuation

Unilever eyes €1B in savings as post-spin-off restructuring gathers pace

China’s services PMI misses expectations at 50.8 in October, composite PMI drops to 52.0

Asia stocks tumble as tech shares slide on U.S. election results

Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033